Tag: Policy + Advocacy Updates

CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Accelerator Grant Programs this session through SB23-066, working with our advanced industries partners and Colorado’s...

Governor Jared Polis gave his 2023 State of the State address to the Colorado General Assembly on Tuesday, January 17th, where he laid out his goals for his second term: “When Colorado reaches our 150...

Colorado’s 2023 legislative session kicked off on Monday, January 9th, with swearing in, certification of election results, and opening day speeches from legislative leaders. Governor Jared Polis took...

CBSA leads Policy + Advocacy to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in our ecosy...

Updated on 1/3/2023 President Biden signed a $1.7 trillion omnibus spending package into law on December 29th, narrowly averting a government shutdown.  In his tweet announcing this news, the Pre...

Colorado BioScience Association is thrilled to welcome Amy Berenbaum Goodman to our team in a newly expanded role, Vice President and Counsel for Policy + Advocacy.  Amy Berenbaum GoodmanVice Presiden...

Prescription drug prices lag inflation, according to new information from the Altarum November 2022 Health Sectors Economic Indicators Briefs. With inflation top of mind for policymakers at the state...

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team continues to monitor and review legislation that could directly affect life sciences...

CBSA urges Congress to pass important legislation, the Pioneering Antimicrobial Subscriptions to End Up-Surging Resistance Act (PASTEUR Act) during the “lame-duck” session. There is limited time to pa...

Colorado BioScience Association (CBSA) recognized two state legislators for their leadership on issues critical to life sciences at the 19th Annual Awards Celebration Presented by AGC Biologics on Nov...